IRhythm Holdings Price to Sales Ratio 2015-2025 | IRTC
Historical PS ratio values for IRhythm Holdings (IRTC) over the last 10 years. The current P/S ratio for IRhythm Holdings as of February 09, 2026 is .
| IRhythm Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-02-09 | 148.50 | 6.71 | |
| 2025-09-30 | 171.99 | $22.12 | 7.77 |
| 2025-06-30 | 153.96 | $20.85 | 7.39 |
| 2025-03-31 | 104.68 | $19.76 | 5.30 |
| 2024-12-31 | 90.17 | $18.99 | 4.75 |
| 2024-09-30 | 74.24 | $18.06 | 4.11 |
| 2024-06-30 | 107.64 | $17.42 | 6.18 |
| 2024-03-31 | 116.00 | $16.73 | 6.93 |
| 2023-12-31 | 107.04 | $16.16 | 6.62 |
| 2023-09-30 | 94.26 | $15.58 | 6.05 |
| 2023-06-30 | 104.32 | $14.97 | 6.97 |
| 2023-03-31 | 124.03 | $14.32 | 8.66 |
| 2022-12-31 | 93.67 | $13.76 | 6.81 |
| 2022-09-30 | 125.28 | $12.79 | 9.80 |
| 2022-06-30 | 108.03 | $12.24 | 8.83 |
| 2022-03-31 | 157.47 | $11.59 | 13.59 |
| 2021-12-31 | 117.69 | $11.02 | 10.68 |
| 2021-09-30 | 58.56 | $11.07 | 5.29 |
| 2021-06-30 | 66.35 | $10.72 | 6.19 |
| 2021-03-31 | 138.86 | $9.82 | 14.13 |
| 2020-12-31 | 237.21 | $9.64 | 24.60 |
| 2020-09-30 | 238.11 | $9.14 | 26.04 |
| 2020-06-30 | 115.89 | $8.74 | 13.25 |
| 2020-03-31 | 81.35 | $8.99 | 9.05 |
| 2019-12-31 | 68.09 | $8.60 | 7.92 |
| 2019-09-30 | 74.11 | $8.05 | 9.20 |
| 2019-06-30 | 79.08 | $7.49 | 10.56 |
| 2019-03-31 | 74.96 | $6.86 | 10.93 |
| 2018-12-31 | 69.48 | $6.19 | 11.23 |
| 2018-09-30 | 94.66 | $5.67 | 16.71 |
| 2018-06-30 | 81.13 | $5.17 | 15.71 |
| 2018-03-31 | 62.95 | $4.74 | 13.28 |
| 2017-12-31 | 56.05 | $4.40 | 12.72 |
| 2017-09-30 | 51.88 | $6.67 | 7.78 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.719B | $0.592B |
| IRHYTHM HLDGS is a digital health care company which creates trusted solutions that detect, predict and prevent disease. IRHYTHM HLDGS, formerly known as iRhythm Technologies Inc., is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.189B | 34.91 |
| Tempus AI (TEM) | United States | $9.769B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.240B | 42.63 |
| Doximity (DOCS) | United States | $5.221B | 22.18 |
| Privia Health (PRVA) | United States | $2.705B | 169.15 |
| Hinge Health (HNGE) | United States | $2.454B | 0.00 |
| Heartflow (HTFL) | United States | $2.362B | 0.00 |
| 10x Genomics (TXG) | United States | $2.355B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.909B | 31.59 |
| Omnicell (OMCL) | United States | $1.664B | 46.34 |
| Azenta (AZTA) | United States | $1.323B | 53.19 |
| Enovis (ENOV) | United States | $1.292B | 6.78 |
| Clover Health Investments (CLOV) | United States | $1.101B | 0.00 |
| Schrodinger (SDGR) | United States | $0.994B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.854B | 0.00 |
| Phreesia (PHR) | United States | $0.736B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.725B | 0.00 |
| Talkspace (TALK) | United States | $0.643B | 129.33 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Claritev (CTEV) | United States | $0.428B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.324B | 0.00 |
| Evolent Health (EVH) | United States | $0.318B | 0.00 |
| Carlsmed (CARL) | United States | $0.310B | 0.00 |
| TruBridge (TBRG) | United States | $0.304B | 13.97 |
| Senseonics Holdings (SENS) | United States | $0.304B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.232B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.228B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.210B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.158B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 5.70 |
| Outset Medical (OM) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.073B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.065B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| HeartBeam (BEAT) | United States | $0.049B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| Precipio (PRPO) | United States | $0.035B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.016B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.007B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |